Cloned (Comment) | Organism |
---|---|
expressed in HEK293 cells | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
rFIXa104A | recombinant FIXa alanine point mutation in loop 2 of the EGF2 domain | Homo sapiens |
rFIXa105A | recombinant FIXa alanine point mutation in loop 2 of the EGF2 domain | Homo sapiens |
rFIXa107A | recombinant FIXa alanine point mutation in loop 2 of the EGF2 domain | Homo sapiens |
rFIXa89A | recombinant FIXa alanine point mutation in loop 1 of the EGF2 domain | Homo sapiens |
rFIXa90A | recombinant FIXa alanine point mutation in loop 1 of the EGF2 domain | Homo sapiens |
rFIXa91A | recombinant FIXa alanine point mutation in loop 1 of the EGF2 domain | Homo sapiens |
rFIXa94A | recombinant FIXa alanine point mutation in loop 1 of the EGF2 domain | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0000068 | - |
Factor X | mutant enzyme rFIXa90A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.0000089 | - |
Factor X | mutant enzyme rFIXa107A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.0000181 | - |
Factor X | mutant enzyme rFIXa90A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.00002 | - |
Factor X | mutant enzyme rFIXa104A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.0000224 | - |
Factor X | mutant enzyme rFIXa94A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.0000251 | - |
Factor X | mutant enzyme rFIXa105A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.0000295 | - |
Factor X | mutant enzyme rFIXa91A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.000034 | - |
Factor X | mutant enzyme rFIXa107A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.0000396 | - |
Factor X | plasma-derived FIXa, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.0000428 | - |
Factor X | plasma-derived FIXa, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.0000629 | - |
Factor X | mutant enzyme rFIXa91A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.000064 | - |
Factor X | mutant enzyme rFIXa94A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.0000787 | - |
Factor X | mutant enzyme rFIXa104A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.0000869 | - |
Factor X | mutant enzyme rFIXa105A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
0.0001542 | - |
Factor X | mutant enzyme rFIXa89A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
factor X + H2O | Homo sapiens | in the presence of FVIIIa (5 units/ml) at 37 °C | factor Xa | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P00740 | - |
- |
Purification (Comment) | Organism |
---|---|
ion exchange chromatography on Q-Sepharose | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
factor X + H2O | - |
Homo sapiens | factor Xa | - |
? | |
factor X + H2O | in the presence of FVIIIa (5 units/ml) at 37 °C | Homo sapiens | factor Xa | - |
? | |
N-alpha-benzyloxycarbonyl-D-arginylglycyl-L-arginine-para-nitroanilide + H2O | - |
Homo sapiens | N-alpha-benzyloxycarbonyl-D-arginylglycyl-L-arginine + para-nitroaniline | - |
? |
Synonyms | Comment | Organism |
---|---|---|
factor IXa | - |
Homo sapiens |
FIXa | - |
Homo sapiens |
Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
2.9 | - |
Factor X | mutant enzyme rFIXa104A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
2.9 | - |
Factor X | mutant enzyme rFIXa94A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
3.3 | - |
Factor X | mutant enzyme rFIXa107A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
3.4 | - |
Factor X | plasma-derived FIXa, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
3.8 | - |
Factor X | mutant enzyme rFIXa105A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
4.1 | - |
Factor X | mutant enzyme rFIXa90A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
5.2 | - |
Factor X | mutant enzyme rFIXa91A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens | |
16.6 | - |
Factor X | mutant enzyme rFIXa89A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 °C | Homo sapiens |